No Data
No Data
No Data
No Data
No Data
Century Therapeutics(IPSC.US) Officer Sells US$15,489.5 in Common Stock
$Century Therapeutics(IPSC.US)$ Officer Russotti Gregory sold 5,000 shares of common stock on Apr 22, 2024 at an average price of $3.0979 for a total value of $15,489.5.Source: Announcement What is st
Futu NewsApr 25 05:00
Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
PHILADELPHIA, April 23, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ:IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and
GlobeNewswireApr 23 19:00
Buy Rating Affirmed for Century Therapeutics Amidst Strong Financial Backing and Promising Clinical Advances
TipRanksApr 16 14:35
Piper Sandler: Reiterates Century Therapeutics (IPSC.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $10.00 to $9.00.
Piper Sandler: Reiterates Century Therapeutics (IPSC.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $10.00 to $9.00.
Zhitong FinanceApr 12 20:50
Piper Sandler Reiterates Overweight on Century Therapeutics, Lowers Price Target to $9
Piper Sandler analyst Edward Tenthoff reiterates Century Therapeutics with a Overweight and lowers the price target from $10 to $9.
Analyst UpgradesApr 12 20:43
Century Therapeutics (IPSC) Receives a Buy From Piper Sandler
TipRanksApr 12 20:29
No Data
No Data